Cabergoline and myocardial infarction Patient Reports February 11, 2012

Cabergoline Side Effects Report #4680717-4
Cabergoline side effect was reported by a Health Professional from on May 20, 2005. Female patient, 85 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: myocardial infarction, oedema peripheral. Cabergoline dosage: unknown. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #4690050-2
Cabergoline side effect was reported by a Health Professional from on May 31, 2005. Female patient, 80 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: blood bicarbonate increased, blood ph decreased, cardiac failure congestive, cardiomegaly, fluid imbalance, myocardial infarction, myocardial ischaemia, oedema peripheral, pco2 increased. Cabergoline dosage: 1 MG (1 MG, QD), ORAL. During the same period patient was treated with MADOPAR, SYMMETREL, MICARDIS, SELBEX, AMLODIPINE, MAGNESIUM OXIDE. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #4678212-1
Cabergoline side effect was reported by a Physician from on May 17, 2005. Female patient, 71 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: myocardial infarction. Cabergoline dosage: 0.5 MG (DAILY), ORAL. During the same period patient was treated with EC DOPARL, ALFACALCIDOL. Patient died on 05/09/2005.

Cabergoline Side Effects Report #4681935-1
Cabergoline side effect was reported by a Physician from on May 23, 2005. Female patient, 71 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac failure, myocardial infarction. Cabergoline dosage: unknown. During the same period patient was treated with EC DOPRAL, ALFACALCIDOL. Patient died on 05/09/2005.


Cabergoline Side Effects Report #4690022-8
Cabergoline side effect was reported by a Physician from on May 31, 2005. Female patient, 71 years of age, was diagnosed with parkinson's disease , osteoporosis , cardiac failure and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac failure, myocardial infarction. Cabergoline dosage: unknown. During the same period patient was treated with EC DOPARL, ALFACALCIDOL, FUROSEMIDE. Patient died on 05/09/2005.

Cabergoline Side Effects Report #4670843-8
Cabergoline side effect was reported by a Physician from on May 09, 2005. Male patient, 60 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: hallucination, myocardial infarction, renal impairment. Cabergoline dosage: 1 MG (1 MG DAILY) ORAL. During the same period patient was treated with EC DOPRAL. Patient died on 11/01/2004.

Cabergoline Side Effects Report #4678213-3
Cabergoline side effect was reported by a Physician from on May 17, 2005. Male patient, 59 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: hallucination, myocardial infarction, renal impairment. Cabergoline dosage: 0.5 MG (DAILY),ORAL. During the same period patient was treated with EC DOPARL, PERMAX, DILAZEP DIHYDROCHLORIDE, URALYT, ALLOPURINOL. Patient died on 11/19/2004.

Cabergoline Side Effects Report #4681933-8
Cabergoline side effect was reported by a Physician from on May 23, 2005. Male patient, 59 years of age, was diagnosed with parkinson's disease , glomerulonephritis proliferative, gout  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: myocardial infarction. Cabergoline dosage: unknown. During the same period patient was treated with EC DOPARL, PERMAX, DILAZEP DIHYDROCHLORIDE, URALYT. Patient died on 11/19/2004.

Cabergoline Side Effects Report #4690021-6
Cabergoline side effect was reported by a Physician from on May 31, 2005. Male patient, 59 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: glomerulonephritis proliferative, hallucination, myocardial infarction, renal impairment. Cabergoline dosage: unknown. During the same period patient was treated with EC DOPRAL, PERMAX, URALYT, ALLOPURINOL. Patient died on 11/19/2004.